Dr. Reddy's Laboratories RDY announced today that it has
launched ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg and
40 mg, a therapeutic equivalent generic version of NEXIUM®
(esomeprazole magnesium) Delayed-Release Capsules in the US market on
September 25, 2015, following the approval by the United States Food &
Drug Administration (USFDA).
The NEXIUM® (esomeprazole magnesium) Delayed-Release Capsules
brand and generic had U.S. sales of approximately $5.2 Billion MAT for
the most recent twelve months ending in July 2015 according to IMS
Health*.
Dr. Reddy's ESOMEPRAZOLE MAGNESIUM DELAYED-RELEASE CAPSULES USP, 20 mg
and 40 mg are available in bottle count size of 30.
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPress Releases
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in